Cargando…
Mechanism of Action and Target Identification: A Matter of Timing in Drug Discovery
Two opposing viewpoints are held regarding the need for understanding a drug's molecular target and mechanism of action. One extreme viewpoint is that it is unnecessary, because, after all, there are many beneficial drugs in use for which the target and mechanism of action remain unknown. A sec...
Autor principal: | Davis, Ronald L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479624/ https://www.ncbi.nlm.nih.gov/pubmed/32891054 http://dx.doi.org/10.1016/j.isci.2020.101487 |
Ejemplares similares
-
Computational drug discovery under RNA times
por: Bernetti, Mattia, et al.
Publicado: (2022) -
NMR in target driven drug discovery: why not?
por: Keiffer, Sébastien, et al.
Publicado: (2020) -
A perspective on multi-target drug discovery and design for complex diseases
por: Ramsay, Rona R., et al.
Publicado: (2018) -
Molecular Biology and Evolution of Cancer: From Discovery to Action
por: Somarelli, Jason A, et al.
Publicado: (2020) -
Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012)